| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
22,715 |
15,336 |
$1.38M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
290 |
290 |
$40K |
| 93000 |
|
1,676 |
1,665 |
$23K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,687 |
1,218 |
$18K |
| 98927 |
|
298 |
122 |
$15K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
100 |
100 |
$10K |
| 99401 |
|
152 |
124 |
$4K |
| 90688 |
|
222 |
222 |
$3K |
| 76536 |
|
38 |
38 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
4,970 |
4,755 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
211 |
209 |
$2K |
| 81002 |
|
1,120 |
1,103 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
358 |
350 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16 |
16 |
$2K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
1,480 |
1,068 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
38 |
38 |
$814.06 |
| 76775 |
|
12 |
12 |
$631.29 |
| 99490 |
Ccm add 20min |
138 |
138 |
$494.73 |
| 99406 |
|
51 |
40 |
$452.41 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
2,811 |
2,311 |
$263.87 |
| 90658 |
|
15 |
15 |
$204.54 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
38 |
25 |
$136.44 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
14 |
13 |
$129.84 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
78 |
68 |
$21.11 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
38 |
37 |
$3.71 |